Oncotarget

Addendum:

Addendum: Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue

PDF  |  Supplementary Files  |  How to cite

Oncotarget. 2025; 16:132-132. https://doi.org/10.18632/oncotarget.28699

Metrics: PDF 432 views  |   ?  

Jyoti Roy1,2, Karson S. Putt1, Domenico Coppola3, Marino E. Leon3, Farah K. Khalil3, Barbara A. Centeno3, Noel Clark4, Valerie E. Stark5, David L. Morse5 and Philip S. Low1,2

1Center for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA
2Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA
3Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA
4Tissue Core, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA
5Department of Cancer Imaging and Metabolism, Imaging and Technology Center of Excellence, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA

Published: March 5, 2025

Copyright: © 2025 Roy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: The Supplementary Material file has been added to this article.

Original article: Oncotarget. 2016; 7:14605–14615. DOI: https://doi.org/10.18632/oncotarget.7522.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28699